MegaETH set to deploy public testnet this week
Quick Take MegaETH’s public testnet deployment is scheduled to start on March 6. The testnet will onboard users from March 10.
MegaETH, a high-performance Ethereum Layer 2 in development, has outlined a structured plan for rolling out its testnet.
The project has scheduled its public testnet deployment to begin on March 6 — just a few days from now.
The rollout is structured in phases. The testnet officially deploys on March 6, marking the start of public access to the network. From March 6 to March 10, the focus will be on onboarding applications and infrastructure teams, allowing developers to refine their deployments and adapt to MegaETH’s architecture. From March 10 onward, users will begin to onboard.
The testnet phase will be a crucial step before MegaETH’s mainnet launch. MegaETH targets up to 100,000 transactions per second. Its architecture involves specialized nodes like sequencers and provers, which are optimized for high performance.
The testnet will offer builders access to 1.68 Ggas/sec (a measure of computational capacity) and 15 ms effective block times in single-threaded performance, the team said .
In June 2024, MegaETH raised $20 million in a seed funding round led by Dragonfly Capital, with participation from Ethereum co-founder Vitalik Buterin, among others. This was followed by a $10 million round on the fundraising platform Echo.
The project also raised 4,964 ETH ($13 million) in early February through its flagship NFT collection, “The Fluffle. "
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Banks retreat, bond discounts, and it's hard to borrow money for the AI construction boom
Discounted sales of high-yield bonds have become the new norm—among this year's $55 billion related bonds, the most recent four issuances were all at a discount; major banks such as Société Générale and Mitsubishi are adopting a more cautious approach; Oracle's force majeure event has further prompted lenders to tighten their terms. With $700 billion in capital expenditures from mega-tech companies competing for financing, combined with rising Treasury yields, the cost of funding for some projects is approaching the break-even point. Developers with lower ratings and less experience are being hit first.

Trading congestion! Bank of America warns: "Buy AI, sell consumer" strategies are increasingly difficult to generate excess returns
Active fund holdings have already fully reflected the theme of "consumption shifting to capital expenditure." It is becoming increasingly difficult to generate excess returns by buying beneficiaries of AI capital expenditure and selling white-collar consumption themes.
Replica of the "Semiconductor Moment": The "Bottleneck Trade" in AI Drug Discovery Is Taking Shape—Who Will Be the Next "Shovel Seller"?
Investor Freda Duan pointed out that AI-driven drug development is shaping structural opportunities similar to "bottleneck trades" in the semiconductor industry. The core logic is that AI turns failed experiments into valuable training data, and wet laboratories are transforming from "medicine making" to "data creation." DNA synthesis, protein production, and CROs may become the earliest beneficiaries as the "pick-and-shovel sellers."
